Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 1
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Sharif N, et al. Front Immunol. 2021 Oct 11;12:714170. doi: 10.3389/fimmu.2021.714170. eCollection 2021. Front Immunol. 2021. PMID: 34707602 Free PMC article.
Pain at the injection site was the most common local symptom in people receiving mRNA vaccines (29%-85% of participants). Fever (0.2%-95%) was the most prevalent in people receiving adenovirus vector vaccines, and fatigue (8.4%-55%) was the most common side e …
Pain at the injection site was the most common local symptom in people receiving mRNA vaccines (29%-85% of participants). Feve …
Revolutionizing pediatric gene and cell therapy: The hope for lipid-based nanoparticles in blood disorders.
Zahedipour F, Gol TM, Wisser S, Ramesh A, Ureña-Bailén G, Jaafari MR, Mezger M. Zahedipour F, et al. Curr Res Transl Med. 2025 Dec;73(4):103545. doi: 10.1016/j.retram.2025.103545. Epub 2025 Oct 3. Curr Res Transl Med. 2025. PMID: 41075357 Free article. Review.
Eventually, authorization and approval of the mRNA-LNP vaccines against COVID-19 (Comirnaty of BioNTech/Pfizer and SpikeVax of Moderna) was another milestone for the development of LNP-based nucleic acid therapies. Later, LNPs were applied successfully for the del …
Eventually, authorization and approval of the mRNA-LNP vaccines against COVID-19 (Comirnaty of BioNTech/Pfizer and SpikeVax …
Considerations for addressing anti-vaccination campaigns: How did we get here and what can we do about it?
Barrett JS, Yang SY, Muralidharan K, Javes V, Oladuja K, Castelli MS, Clayton N, Liu J, Ramos A. Barrett JS, et al. Clin Transl Sci. 2022 Jun;15(6):1380-1386. doi: 10.1111/cts.13273. Epub 2022 Apr 8. Clin Transl Sci. 2022. PMID: 35320620 Free PMC article. Review.
A course on vaccine development asked students to write a blog addressing general anti-vaccination strategies and their significance today, in the context of the resistance seen against novel SARS-CoV-2 mRNA vaccines. This perspective explores how and why these effo …
A course on vaccine development asked students to write a blog addressing general anti-vaccination strategies and their significance today, …
Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trial.
Kelly E, Greenland M, de Whalley P, Macaulay GC, Aley PK, Plested E, Koleva S, Cotton J, Kinch J, Madupuri T, Read RC, Ramsay M, Cameron C, Turner DPJ, Heath P, Connor P, Cathie K, Faust SN, Banerjee I, Man K, Shackley F, O' Riordan S, Owens S, Polychronakis T, Trari Belhadef H, Mujadidi Y, Singha A, Cantrell L, Clutterbuck E, Anslow R, James T, Hallis B, Matheson M, Chang L, Lambe T, Nguyen-Van-Tam JS, Snape MD, Minassian AM, Liu X. Kelly E, et al. J Infect. 2026 Jan;92(1):106663. doi: 10.1016/j.jinf.2025.106663. Epub 2025 Dec 1. J Infect. 2026. PMID: 41338394 Free article. Clinical Trial.
Although recruitment ceased early, the sample size required to fulfil the primary objective was met. FINDINGS: 281 participants were recruited (mean age 14 years old, 57% female). ...
Although recruitment ceased early, the sample size required to fulfil the primary objective was met. FINDINGS: 281 participants were …